US2020331997A1PendingUtilityA1

Methods for treating psoriasis

72
Assignee: ENZO THERAPEUTICS INCPriority: Oct 8, 2004Filed: Jul 2, 2020Published: Oct 22, 2020
Est. expiryOct 8, 2024(expired)· nominal 20-yr term from priority
Inventors:Yaron IlanEran Elinav
A61K 38/2264C07K 16/2869C07K 16/26C07K 14/72C07K 14/5759A61N 5/10A61K 38/22A61K 38/1796A61K 38/16A61K 38/02A61P 17/06A61K 45/06A61K 39/3955A61P 3/10C07K 2317/30A61P 15/08C07K 2317/76A61P 19/02A61P 37/04A61P 37/02A61P 37/00A61P 1/00A61P 35/02A61P 1/16A61P 29/00A61K 2039/505A61P 35/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods for treating psoriasis and other indications by inhibiting leptin activity.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating psoriasis, comprising: 
     
     
         1 . A method for treating psoriasis, comprising:
 administering to a human patient having psoriasis, a therapeutically effective amount of a protein that binds to and antagonizes a leptin receptor,   wherein the protein is selected from the group consisting of an antibody and an antibody fragment.   
     
     
         2 . The method of  claim 1 , wherein the protein is an antibody or antibody fragment that binds to and antagonizes the leptin receptor. 
     
     
         3 . The method of  claim 2 , wherein the protein is a monoclonal antibody or a fragment of a monoclonal antibody.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.